TPRKB

TPRKB

Target · tRNA modification subunit

TPRKB TP53RK binding protein · EKC/KEOPS complex subunit TPRKB

TPRKB (TP53RK binding protein, also known as CGI-121 or CGI121) is a subunit of the EKC/KEOPS complex, which is required for threonylcarbamoyl modification of adenosine 37 in certain tRNAs. It acts as an allosteric effector that regulates the activity of the complex. Browse Assay Genie's current range of TPRKB research reagents below, or read on for the biology behind the target.

Cytosol and nucleusEKC/KEOPS complex subunitLinked to Galloway-Mowat syndrome 5
175 aa
Protein length
~20 kDa
Molecular weight
2p13.1
Gene locus
CGI121/TPRKB
Protein family
Target information

What is TPRKB (TP53RK binding protein)?

TPRKB is a component of the EKC/KEOPS complex, which is required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. The complex is probably involved in transferring the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37. Within the complex, TPRKB acts as an allosteric effector that regulates t(6)A activity. The source annotation notes that TPRKB is not required for the tRNA modification itself.

The TPRKB gene encodes the EKC/KEOPS complex subunit TPRKB, a member of the CGI121/TPRKB family. HGNC places it in the KEOPS complex gene group. The protein is located in the cytosol and nucleus, and NCBI Gene lists protein kinase binding among its enabled activities, consistent with its name as the TP53RK binding protein. Mouse and rat both have a Tprkb ortholog, so the target can be studied in common model systems.

TPRKB is also known as CGI-121 or CGI121. It is involved in tRNA threonylcarbamoyladenosine modification and is implicated in Galloway-Mowat syndrome 5. Researchers studying tRNA modification, translation fidelity, or the biology of KEOPS-related disease can use TPRKB as a defined entry point into the complex and its regulation.

tRNA modification biology

TPRKB is part of the EKC/KEOPS complex needed for t(6)A37 formation in tRNAs that read codons beginning with adenine.

Allosteric regulation studies

TPRKB acts as an allosteric effector of the complex, making it relevant to how t(6)A activity is regulated.

Galloway-Mowat syndrome research

TPRKB is implicated in Galloway-Mowat syndrome 5, linking the KEOPS complex to human disease.

Protein complex and kinase binding

TPRKB enables protein kinase binding and is a partner in the KEOPS complex, supporting interaction and complex-assembly studies.

Background

TPRKB frequently asked questions

What does TPRKB do?

TPRKB is a subunit of the EKC/KEOPS complex, which is required for threonylcarbamoyl modification of adenosine 37 (t(6)A37) in tRNAs reading codons that begin with adenine. TPRKB acts as an allosteric effector that regulates the complex's t(6)A activity, though it is not required for the tRNA modification itself.

What other names does TPRKB go by?

TPRKB stands for TP53RK binding protein. Its UniProt name is EKC/KEOPS complex subunit TPRKB, and it is also known as CGI-121 or CGI121. It belongs to the CGI121/TPRKB family and is classed by HGNC in the KEOPS complex gene group.

Is TPRKB conserved and linked to disease?

Mouse and rat both carry a Tprkb ortholog. In humans, TPRKB is implicated in Galloway-Mowat syndrome 5, according to NCBI Gene. As always, check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.

Explore

Related targets

Other KEOPS complex subunits and tRNA modification targets may be listed here as further pages are added.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y3C4; product specifications from Assay Genie datasheets.

TPRKB Product listing